DSPE-PEG3400
DSPE-PEG3400 is a phospholipid-PEG polymer conjugate that can be used in drug delivery applications. DSPE-PEG3400 serves as a material for preparing nanocarriers, which is used to prolong blood circulation time, enhance stability and improve encapsulation efficiency.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 145035-96-7
- 分子式: (C2H4O)nC43H86NO9P
- 分子量:3400 (Average)
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体外実験
DSPE-PEG3400, as a component of PDT biomimetic liposomes (PB Lipo), contributes to the formation of stable, biocompatible liposomes with efficient ICG encapsulation, sustained drug release, and laser-triggered accelerated ICG release[1].
DSPE-PEG3400 stabilized poly-TTG-SS nanoparticles are taken up by human prostate cancer C4-2 cells in a time-dependent manner, with increasing intracellular accumulation observed from 1 h to 6 h of incubation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 145035-96-7
-
分子量 3400 (Average)
-
分子式 (C2H4O)nC43H86NO9P
-
SMILES
O=C(CCCCCCCCCCCCCCCCC)OCC(COP(O)(OCCNCCOCCO)=O)OC(CCCCCCCCCCCCCCCCC)=O.[n]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Li T, et al. Photodynamic Biomimetic Liposomes Targeted to the Endoplasmic Reticulum Enhance Combined Immunotherapy for Triple-Negative Breast Cancer. ACS Appl Mater Interfaces. 2025;17(17):25112-25127. [Content Brief]
[2]. Li L, et al. Tumor-microenvironment responsive nano-carrier system for therapy of prostate cancer. J Mater Sci Mater Med. 2023;34(10):46. Published 2023 Sep 21. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)